The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control
Open accessAbstract
The target of rapamycin (TOR) proteins in Saccharomyces cerevisiae, TOR1 and TOR2, redundantly regulate growth in a rapamycin-sensitive manner. TOR2 additionally regulates polarization of the actin cytoskeleton in a rapamycin-insensitive manner. We describe two functionally distinct TOR complexes. TOR Complex 1 (TORC1) contains TOR1 or TOR2, KOG1 (YHR186c), and LST8. TORC2 contains TOR2, AVO1 (YOL078w), AVO2 (YMR068w), AVO3 (YER093c), and LST8. FKBP-rapamycin binds TORC1, and TORC1 disruption mimics rapamycin treatment, suggesting that TORC1 mediates the rapamycin-sensitive, TOR-shared pathway. FKBP-rapamycin fails to bind TORC2, and TORC2 disruption causes an actin defect, suggesting that TORC2 mediates the rapamycin-insensitive, TOR2-unique pathway. Thus, the distinct TOR complexes account for the diversity, specificity, and selective rapamycin inhibition of TOR signaling. TORC1 and possibly TORC2 are conserved from yeast to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“specifically, mTORC2 contains the mTOR, Rictor, LST8 and SIN1 proteins (Loewith et al., 2002).”
From Skeletal Muscle Ribosome and Mitochondrial Biogenesis in Response to Different Exercise Training Modalities (2021) · cites this paper as Loewith et al., 2002
In the citing paper
“which was discovered after it was shown that rapamycin is able to inhibit mTORC1 via binding to the protein FKBP12 (REFS31,32).”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [31]
In the citing paper
“mTOR is present in two complexes, mTORC1 (associated with ‘raptor’) and mTORC2 (associated with ‘rictor’), accounting for the diversity, specificity and selectivity of rapamycin-mediated inhibition of TOR signalling”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [31]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M. S., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,996
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,281
Sherman, F. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)94004-v · Cited by 4,078
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Bähler, J., Wu, J., Longtine, M. S., Shah, N. G., Mckenzie, A., Steever, A. B., Wach, A., Philippsen, P., & Pringle, J. R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199807)14:10 · Cited by 2,208
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Self-citationTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,914
Self-citationRaptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Sujuti, H., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
The Tandem Affinity Purification (TAP) Method: A General Procedure of Protein Complex Purification
Puig, Ó., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado‐Nilsson, E., Wilm, M. S., & Séraphin, B. (2001) · Methods · doi:10.1006/meth.2001.1183 · Cited by 1,784
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Cited by
Sorted by citations
Items 301–400 of 1,001
Liu, L., Luo, Y., Chen, L., Shen, T., Xu, B., Chen, W., Zhou, H., Han, X., & Huang, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141168 · Cited by 144
Mechanism and Regulation of Protein Synthesis in Saccharomyces cerevisiae
Dever, T. E., Kinzy, T. G., & Pavitt, G. D. (2016) · Genetics · doi:10.1534/genetics.115.186221 · Cited by 159
Structure-Function Analysis of Core STRIPAK Proteins
Kean, M. J., Ceccarelli, D. F. J., Goudreault, M., Sanches, M., Tate, S. A., Larsen, B. G., Gibson, L. C. D., Derry, W. B., Scott, I. C., Pelletier, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214486 · Cited by 145
Zhang, W., Du, G., Zhou, J., & Chen, J. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-17 · Cited by 150
TOR Signaling in Caenorhabditis elegans Development, Metabolism, and Aging
Blackwell, T. K., Sewell, A. K., Wu, Z., & Han, M. (2019) · Genetics · doi:10.1534/genetics.119.302504 · Cited by 148
Urano, J., Sato, T., Matsuo, T., Otsubo, Y., Yamamoto, M. P., & Tamanoi, F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608510104 · Cited by 140
Bachar-Wikström, E., Ariav, Y., Ketzinel‐Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004954 · Cited by 142
The Opposing Actions of Target of Rapamycin and AMP-Activated Protein Kinase in Cell Growth ControlPreprint
Hindupur, S. K., González, A., & Hall, M. N. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019141 · Cited by 147
Self-citationGoodman, C. A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_17 · Cited by 145
LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway
Chen, E. J., & Kaiser, C. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200210141 · Cited by 139
van Dam, T. J. P., Zwartkruis, F. J. T., Bos, J. L., & Snel, . (2011) · Journal of Molecular Evolution · doi:10.1007/s00239-011-9469-9 · Cited by 147
mTOR signaling for biological control and cancer
Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 143
Ali, S. M., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500125200 · Cited by 138
Zheng, M., Wang, Y., Wu, X., Wu, S., Lu, B.-J., Dong, M., Zhang, H., Sun, P., Lin, S., Guan, K., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2168 · Cited by 142
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
Ferrín, G., Misas, M. G., Amado, V., Rodríguez‐Perálvarez, M., & de la Mata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041266 · Cited by 141
Connecting metabolism and reproduction: roles of central energy sensors and key molecular mediators
Roa, J., & Tena-Sempere, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.027 · Cited by 136
Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation
Barquilla, A., Crespo, J. L., & Navarro, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802668105 · Cited by 139
Self-citationBeugnet, A., Wang, X., & Proud, C. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308573200 · Cited by 141
Genome‐wide lethality screen identifies new PI4,5P2 effectors that regulate the actin cytoskeleton
Audhya, A., Loewith, R., Parsons, A. B., Gao, L., Tabuchi, M., Zhou, H., Boone, C. M., Hall, M. N., & Emr, S. D. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600384 · Cited by 136
Self-citationNiles, B. J., Mogri, H., Hill, A., Vlahakis, A., & Powers, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117563109 · Cited by 134
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Li, W., Petrimpol, M., Molle, K. D., Hall, M. N., Battegay, E., & Humar, R. (2006) · Circulation Research · doi:10.1161/01.res.0000253094.03023.3f · Cited by 138
Self-citationRe-evaluating AKT regulation: role of TOR complex 2 in tissue growthPreprint
Hietakangas, V., & Cohen, S. M. (2007) · Genes & Development · doi:10.1101/gad.416307 · Cited by 134
Hartman, T. R., Liu, D., Zilfou, J. T., Robb, V. A., Morrison, T. A., Watnick, T. J., & Henske, E. P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn325 · Cited by 136
Roles of the insulin signaling pathway in insect development and organ growth
Lin, X., & Smagghe, G. J. (2018) · Peptides · doi:10.1016/j.peptides.2018.02.001 · Cited by 133
Nutritional control via Tor signaling in Saccharomyces cerevisiae
Rohde, J. R., Bastidas, R. J., Puria, R., & Cardenas, M. E. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.02.013 · Cited by 132
Regulation of chemotaxis by the orchestrated activation of Ras, PI3K, and TOR
Sasaki, A. T., & Firtel, R. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.04.007 · Cited by 133
An emerging role for TOR signaling in mammalian tissue and stem cell physiology
Russell, R. C., Fang, C., & Guan, K. (2011) · Development · doi:10.1242/dev.058230 · Cited by 136
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira, M. N. N., Lima‐Filho, R. A. S., & Felice, F. G. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.014 · Cited by 133
Cryo-EM structure of human mTOR complex 2
Chen, X., Liu, M., Tian, Y., Li, J., Qi, Y., Zhao, D., Wu, Z., Huang, M., Wong, C. C. L., Wang, H., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0029-3 · Cited by 138
Leucine in food mediates some of the postprandial rise in plasma leptin concentrations
Lynch, C. J., Gern, B., Lloyd, C., Hutson, S. M., Eicher, R., & Vary, T. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00462.2005 · Cited by 131
Dames, S. A., Mulet, J. M., Rathgeb–Szabo, K., Hall, M. N., & Grzesiek, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501116200 · Cited by 130
Self-citationDNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer
Tirado-Hurtado, I., Fajardo, W., & Pinto, J. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00106 · Cited by 134
AKT Activation in Human Glioblastomas Enhances Proliferation via TSC2 and S6 Kinase Signaling
Riemenschneider, M. J., Betensky, R. A., Pasedag, S. M., & Louis, D. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0364 · Cited by 132
Fuchs, B. C., Finger, R., Onan, M. C., & Bode, B. P. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00330.2006 · Cited by 137
PI3-kinase and TOR: PIKTORing cell growth
Richardson, C. J., Schalm, S. S., & Blenis, J. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.023 · Cited by 130
Mitochondria, reactive oxygen species, and chronological aging: A message from yeast
Pan, Y. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.08.007 · Cited by 128
Hallett, J. E. H., Luo, X., & Capaldi, A. P. (2014) · Genetics · doi:10.1534/genetics.114.168369 · Cited by 131
Fadri‐Moskwik, M., Daquinag, A. C., Wang, S., Xue, T., & Kunz, J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0564 · Cited by 128
Impact of Immune-Modulatory Drugs on Regulatory T Cell
Furukawa, A., Wisel, S. A., & Tang, Q. (2016) · Transplantation · doi:10.1097/tp.0000000000001379 · Cited by 130
Thinking globally and acting locally with TOR
Arsham, A. M., & Neufeld, T. P. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.09.005 · Cited by 127
Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
Wu, X., Xu, Y., Liang, Q., Yang, X., Huang, J., Wang, J., Zhang, H., & Shi, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875372 · Cited by 131
Choi, K. M., McMahon, L. P., & Lawrence, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301142200 · Cited by 128
Shevchenko, A., Roguev, A., Schaft, D., Buchanan, L., Habermann, B. H., Şakalar, Ç., Thomas, H., Krogan, N. J., Shevchenko, A., & Stewart, A. F. (2008) · Genome biology · doi:10.1186/gb-2008-9-11-r167 · Cited by 129
Evolutionary Conservation of the Components in the TOR Signaling Pathways
Tatebe, H., & Shiozaki, K. (2017) · Biomolecules · doi:10.3390/biom7040077 · Cited by 130
Vitamin D3 Induces Autophagy of Human Myeloid Leukemia Cells
Wang, J., Lian, H., Zhao, Y. L., Kauss, M. A., & Spindel, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801716200 · Cited by 126
PP2AT61ɛ Is an Inhibitor of MAP4K3 in Nutrient Signaling to mTOR
Yan, L., Mieulet, V., Burgess, D. J., Findlay, G. M., Sully, K., Procter, J., Goris, J., Janssens, V., MORRICE, N. A., & Lamb, R. F. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.031 · Cited by 124
Borreguero-Muñoz, N., Fletcher, G., Aguilar‐Aragon, M., Elbediwy, A., Vincent‐Mistiaen, Z. I., & Thompson, B. J. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000509 · Cited by 124
Üstünel, B. E., Magnuson, B., Acosta-Jaquez, H. A., Keller, J. A., Feener, E. P., & Fingar, D. C. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05437-11 · Cited by 129
Uritani, M., Hidaka, H., Hotta, Y., Ueno, M., Ushimaru, T., & Toda, T. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.01025.x · Cited by 124
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Kolesnichenko, M., Hong, L., Liao, R., Vogt, P. K., & Sun, P. (2012) · Cell Cycle · doi:10.4161/cc.20683 · Cited by 123
Regulation of autophagy in yeast Saccharomyces cerevisiae
Cebollero, E., & Reggiori, F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.008 · Cited by 128
mTOR Signaling from Cellular Senescence to Organismal Aging
Xu, S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500263 · Cited by 125
mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells
Goncharova, E. A., Goncharov, D. A., Li, H., Pimtong, W., Lu, S. M., Khavin, I., & Krymskaya, V. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01061-10 · Cited by 122
TOR signaling in invertebrates
Soulard, A., Cohen, A., & Hall, M. N. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.007 · Cited by 124
Self-citationEasley, C. A., Ben‐Yehudah, A., Redinger, C. J., Oliver, S. L., Varum, S., Eisinger, V. M., Carlisle, D. L., Donovan, P. J., & Schatten, G. P. (2010) · Cellular Reprogramming · doi:10.1089/cell.2010.0011 · Cited by 122
Rapamycin activates Tap42‐associated phosphatases by abrogating their association with Tor complex 1
Yan, G., Shen, X., & Jiang, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601239 · Cited by 120
The Systemic Control of GrowthPreprint
Boulan, L., Milán, M., & Léopold, P. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019117 · Cited by 120
A Critical Kinase Cascade In Neurological Disorders: Pi3K, Akt and Mtor
Chong, Z. Z., Shang, Y., Wang, S., & Maiese, K. (2012) · Future Neurology · doi:10.2217/fnl.12.72 · Cited by 122
Opposite Effects of Tor1 and Tor2 on Nitrogen Starvation Responses in Fission Yeast
Weisman, R., Roitburg, I., Schonbrun, M., Harari-Steinfeld, R., & Kupiec, M. (2006) · Genetics · doi:10.1534/genetics.106.064170 · Cited by 119
Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin
Chong, Z. Z., Shang, Y. C., Wang, S., & Maiese, K. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.08.001 · Cited by 119
Key factors in mTOR regulation
Bai, X., & Jiang, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0163-7 · Cited by 123
Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
Barrett, D., Brown, V. I., Grupp, S. A., & Teachey, D. T. (2012) · Pediatric Drugs · doi:10.1007/bf03262236 · Cited by 121
Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
Scholz, G., Jandus, C., Zhang, L., Grandclément, C., López‐Mejía, I. C., Soneson, C., Delorenzi, M., Fajas, L., Held, W., Dormond, O., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.019 · Cited by 120
Jhanwar‐Uniyal, M., Amin, A. G., Cooper, J., Das, K., Schmidt, M. H., & Murali, R. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.12.001 · Cited by 121
TORC1 organized in inhibited domains (TOROIDs) regulate TORC1 activity
Prouteau, M., Desfosses, A., Sieben, C., Bourgoint, C., Mozaffari, N. L., Demurtas, D., MITRA, A. K., Guichard, P., Manley, S., & Loewith, R. (2017) · Nature · doi:10.1038/nature24021 · Cited by 122
Self-citationBiochemical Genetic Pathways that Modulate Aging in Multiple Species: Figure 1.Preprint
Bitto, A., Wang, A. M., Bennett, C. F., & Kaeberlein, M. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025114 · Cited by 122
Therapeutic targeting of the mTOR ‐signalling pathway in cancer: benefits and limitations
Moschetta, M., Reale, A., Marasco, C., Vacca, A., & Carratù, M. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12749 · Cited by 119
TOR signaling never gets old: Aging, longevity and TORC1 activity
Evans, D. S., Kapahi, P., Hsueh, W., & Kockel, L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.001 · Cited by 118
mTOR Signaling in Parkinson’s Disease
Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 117
Macropinocytosis, mTORC1 and cellular growth control
Yoshida, S., Pacitto, R., Inoki, K., & Swanson, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2710-y · Cited by 114
Current development of the second generation of mTOR inhibitors as anticancer agents
Zhou, H., & Huang, S. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10281 · Cited by 114
An overview of rapamycin: from discovery to future perspectives
Yoo, Y. J., Kim, H., Park, S. R., & Yoon, Y. J. (2016) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-016-1834-7 · Cited by 114
Regulations of sugar transporters: insights from yeast
Horák, J. (2013) · Current Genetics · doi:10.1007/s00294-013-0388-8 · Cited by 113
Wang, Y., Bai, Y., Qin, L., Zhang, P., Yi, T., Teesdale, S. A., Zhao, L., Pober, J. S., & Tellides, G. (2007) · Circulation Research · doi:10.1161/circresaha.107.151068 · Cited by 112
SEACing the GAP that nEGOCiates TORC1 activation
Panchaud, N., Gulli, M., & VIRGILIO, C. D. (2013) · Cell Cycle · doi:10.4161/cc.26000 · Cited by 115
The mTORC2 signaling network: targets and cross-talks
Ragupathi, A., Kim, C., & Jacinto, E. (2024) · Biochemical Journal · doi:10.1042/bcj20220325 · Cited by 122
Self-citationWang, L., Rhodes, C. J., & Lawrence, J. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603566200 · Cited by 112
Salem, A. F., Whitaker‐Menezes, D., Zhao, L., Martinez‐Outschoorn, U., Tanowitz, H. B., Zoubi, M. S. A., Howell, A., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.20920 · Cited by 113
Regulation of macroautophagy in Saccharomyces cerevisiae
Inoue, Y., & Klionsky, D. J. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.03.009 · Cited by 113
mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Marafie, S. K., Al‐Mulla, F., & Abubaker, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116141 · Cited by 119
Li, H., Wen, X., Ren, Y., Fan, Z., Zhang, J., He, G., & Fu, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02072-1 · Cited by 113
Liao, X., Majithia, A. R., Huang, X., & Kimmel, A. R. (2008) · Amino Acids · doi:10.1007/s00726-008-0100-3 · Cited by 112
Core signaling pathways of survival/death in autophagy-related cancer networks
Wang, S., Yu, Q., Zhang, R., & Liu, B. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.010 · Cited by 111
Autophagic pathways as new targets for cancer drug development
Liu, B., Cheng, Y., Liu, Q., Bao, J., & Yang, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.118 · Cited by 109
Rebnegger, C., Graf, A. B., Valli, M., Steiger, M. G., Gasser, B., Maurer, M., & Mattanovich, D. (2013) · Biotechnology Journal · doi:10.1002/biot.201300334 · Cited by 110
Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases
Rüegg, M. A., & Glass, D. J. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100537 · Cited by 114
Amino acids control blood glucose levels through mTOR signaling
Fan, J., Yuan, Z., Burley, S. K., Libutti, S. K., & Zheng, X.-F. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151240 · Cited by 110
Sense and sensibility: nutritional response and signal integration in yeast
Schneper, L. M., Düvel, K., & Broach, J. R. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.10.002 · Cited by 110
CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1
Murooka, T. T., Rahbar, R., Platanias, L. C., & Fish, E. N. (2008) · Blood · doi:10.1182/blood-2007-11-125039 · Cited by 110
Xue, Q., Hopkins, B. D., Perruzzi, C. A., Udayakumar, D., Sherris, D., & Benjamin, L. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2058 · Cited by 109
Cellular quiescence: are controlling genes conserved?
Yanagida, M. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.09.006 · Cited by 108
A Novel Proteomics Approach for the Discovery of Chromatin-associated Protein Networks
Lambert, J., MITCHELL, L. A., Rudner, A. D., Baetz, K., & Figeys, D. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800447-mcp200 · Cited by 110
Muhammed Jamsheer, K., Jindal, S., & Laxmi, A. (2019) · Journal of Experimental Botany · doi:10.1093/jxb/erz107 · Cited by 107
Roelants, F. M. (2004) · Microbiology · doi:10.1099/mic.0.27286-0 · Cited by 107
Role of the Fusarium fujikuroi TOR Kinase in Nitrogen Regulation and Secondary Metabolism
Teichert, S., Wottawa, M., Schönig, B., & Tudzynski, B. (2006) · Eukaryotic Cell · doi:10.1128/ec.00039-06 · Cited by 107
Endoplasmic Reticulum and Golgi Localization Sequences for Mammalian Target of Rapamycin
Liu, X., & Zheng, X.-F. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0406 · Cited by 107
Energy balance and puberty onset: Emerging role of central mTOR signaling
Roa, J., & Tena-Sempere, M. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.05.003 · Cited by 106
Hallett, J. E. H., Luo, X., & Capaldi, A. P. (2015) · eLife · doi:10.7554/elife.09181 · Cited by 112
The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1
Böhm, R., Imseng, S., Jakob, R. P., Hall, M. N., Maier, T., & Hiller, S. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.031 · Cited by 111
Self-citationHuman Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling
Schroder, W. A., Buck, M., Cloonan, N., Hancock, J. F., Suhrbier, A., Sculley, T. B., & Bushell, G. R. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.013 · Cited by 106
Metadata
- Authors
- Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N.
- Affiliations
- University of Basel (CH)
- Corresponding author
- Hall, Michael N.
- ORCID
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 10
- Issue
- 3
- Pages
- 457-468
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2152600551
- Cited by
- 1,886
- References
- 59
- Citations by year
- 2026: 37 · 2025: 47 · 2024: 68 · 2023: 65 · 2022: 75 · 2021: 79 · 2020: 70 · 2019: 76 · 2018: 76 · 2017: 100 · 2016: 68 · 2015: 115 · 2014: 97 · 2013: 103 · 2012: 135
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- TOR signaling, TOR1, TOR2, rapamycin sensitivity, cell growth regulation, LST8, Saccharomyces cerevisiae
- MeSH terms
- Actins, Animals, Antifungal Agents, Cell Line, Cytoskeleton, Fungal Proteins, Glycogen, Humans, Protein Binding, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Tissue Distribution, Signal Transduction, Phosphotransferases (Alcohol Group Acceptor), Genes, Reporter, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Sirolimus, Tacrolimus Binding Proteins, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review